David M. Rubenstein, a director at Carlyle Group Inc. ($CG), sold shares on the open market once in the last 365 days for a total of $35.3 million. His most recent sale occurred on December 10, 2025. This places him 427th among 11,678 insiders in our database ranked by highest sales volume, well above the average of $8.6 million per insider and 6.4 transactions. Rubenstein made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 19, 2026 | Carlyle Group Inc. | $CG | Rubenstein David M. | Director | S | Common Stock | 500000 | $46.68 | 27,399,644.0000 | 376,487,705 | 1.79% | 0.13% |
| March 19, 2026 | Carlyle Group Inc. | $CG | Rubenstein David M. | Director | G | Common Stock | 100000 | $0.00 | 27,899,644.0000 | 376,487,705 | 0.36% | 0.03% |
| Dec. 10, 2025 | Carlyle Group Inc. | $CG | Rubenstein David M. | Director | S | Common Stock | 625000 | $56.55 | 27,999,644.0000 | 376,487,705 | 2.18% | 0.17% |
| Dec. 10, 2025 | Carlyle Group Inc. | $CG | Rubenstein David M. | Director | G | Common Stock | 625000 | $0.00 | 28,624,644.0000 | 376,487,705 | 2.14% | 0.17% |
| Aug. 5, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | M | Common Stock | 850 | $0.00 | 1,527.0000 | 384,000,000 | 125.55% | 0.00% |
| Aug. 5, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | M | Restricted Stock Units | 850 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | M | Common Stock | 677 | $0.00 | 677.0000 | 384,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Restricted Stock Units | 8116 | $0.00 | 8,116.0000 | 384,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Stock Option (Right to Buy) | 12756 | $0.00 | 12,756.0000 | 384,000,000 | 9999.99% | 0.00% |
| April 30, 2025 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | M | Restricted Stock Units | 677 | $0.00 | 0.0000 | 384,000,000 | 100.00% | 0.00% |
| Aug. 5, 2024 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Stock Option (Right to Buy) | 5051 | $0.00 | 5,051.0000 | 382,000,000 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Stock Option (Right to Buy) | 4065 | $0.00 | 4,065.0000 | 382,000,000 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Restricted Stock Units | 850 | $0.00 | 850.0000 | 382,000,000 | 9999.99% | 0.00% |
| Aug. 5, 2024 | Moderna, Inc. | $MRNA | Rubenstein David M. | Director | A | Restricted Stock Units | 677 | $0.00 | 677.0000 | 382,000,000 | 9999.99% | 0.00% |